Florida Finance Today
SEE OTHER BRANDS

News on finance and banking in Florida

Florida Finance Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Finance Today.

Press releases published on April 1, 2025

NowVertical Reports Record 2024 Financial Results

NowVertical Reports Record 2024 Financial Results

Company Hosting Investor Webinar on April 2, 2025, at 10:00 AM EST Q4 2024 revenue was $10.9 million, up 94% Y/Y excluding recent divestitures On a reported basis, Q4 2024 revenue increased 8% Y/Y Q4 2024 Net Income was $0.6 million, up 115% Y/Y excluding …

Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces Its Net Asset Value and Asset Coverage Ratios as of March 31, 2025

Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces Its Net Asset Value and Asset Coverage Ratios as of March 31, 2025

HOUSTON, April 01, 2025 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under …

UPDATE – Reborn Coffee Provides Fourth Quarter and Full Year 2024 Corporate Update and Financial Results

UPDATE – Reborn Coffee Provides Fourth Quarter and Full Year 2024 Corporate Update and Financial Results

FY 2024 Annual Revenue Growth to $5.9 Million and Strong 31% Increase in Q4 Revenue to $1.8 Million Approved as U.S. Franchisor and Signed Commitments for 33 New Locations Through a Combination of Area Development and Franchise Agreements BREA, Calif., …

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …

Partners Value Investments Completes Amalgamation

Partners Value Investments Completes Amalgamation

TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Partners Value Investments L.P. (TSXV: PVF.UN, TSXV: PVF.PR.U) (the “Partnership”) and Partners Value Investments Inc. (TSXV: PVF.WT) (“PVII”) today announced the successful completion of a short form vertical …

Business First Bancshares, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call

Business First Bancshares, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call

BATON ROUGE, La., April 01, 2025 (GLOBE NEWSWIRE) -- Business First Bancshares, Inc. (Nasdaq: BFST), the parent company of b1BANK, is scheduled to release first quarter 2025 earnings after market close on Thursday, April 24, 2025. Executive management will …

Stryve Foods, Inc. Announces Preliminary FY 2024 Financials and Filing of Form 12b-25 to Extend Time to File FY 2024 Annual Report

Stryve Foods, Inc. Announces Preliminary FY 2024 Financials and Filing of Form 12b-25 to Extend Time to File FY 2024 Annual Report

Full Year ‘24 Net Sales of $21.0 Million Up 18.5% Year-over-Year Adjusted EBITDA Loss Improved by 32.4% Versus Prior Year Significant Balance Sheet Transformation Underway in 2025 PLANO, Texas, April 01, 2025 (GLOBE NEWSWIRE) -- Stryve Foods, Inc. (OTC: …

CNL STRATEGIC CAPITAL ANNOUNCES  OPERATING RESULTS FOR YEAR-END 2024

CNL STRATEGIC CAPITAL ANNOUNCES OPERATING RESULTS FOR YEAR-END 2024

Orlando, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- CNL Strategic Capital, LLC (“CNL Strategic Capital,” the “Company” or “we”) seeks to provide current income and long-term appreciation to investors by acquiring controlling equity stakes in combination with …

Colliers Announces Voting Results

Colliers Announces Voting Results

TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Colliers International Group Inc. (TSX: CIGI; NASDAQ: CIGI) (“Colliers” or the “Company”) today announced that at its annual meeting of shareholders held virtually on April 1, 2025, the ten director nominees …

PIMCO Closed-End Funds Declare Monthly Common Share Distributions

PIMCO Closed-End Funds Declare Monthly Common Share Distributions

NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- The Boards of Trustees/Directors of the PIMCO closed-end funds below (each, a “Fund” and, collectively, the “Funds”) have declared a monthly distribution for each Fund’s common shares as summarized below. The …

Petrus Resources Declares Monthly Dividend for April 2025

Petrus Resources Declares Monthly Dividend for April 2025

CALGARY, Alberta, April 01, 2025 (GLOBE NEWSWIRE) -- Petrus Resources Ltd. (“Petrus” or the “Company”) (TSX: PRQ) is pleased to confirm that its Board of Directors has declared a monthly dividend in the amount of $0.01 per share payable April 30, 2025, to …

Element to Announce Q1 2025 Results and Host Conference Call on May 1, 2025

Element to Announce Q1 2025 Results and Host Conference Call on May 1, 2025

TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Element Fleet Management Corp. (TSX: EFN) (“Element” or the “Company”), the largest publicly traded, pure-play automotive fleet manager in the world, will hold its Q1 2025 results conference call and webcast for …

Lumine Group Completes the Purchase of Vidispine

Lumine Group Completes the Purchase of Vidispine

TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Lumine Group Inc. (“Lumine Group”) today announced the completion of the purchase of the Vidispine brand and business assets (“Vidispine”) from Arvato Systems, a subsidiary of Bertelsmann SE …

Inventiva announces completion of enrollment in the Phase 3 NATiV3 clinical trial of lanifibranor in patients with MASH and advanced fibrosis

Inventiva announces completion of enrollment in the Phase 3 NATiV3 clinical trial of lanifibranor in patients with MASH and advanced fibrosis

Target enrollment exceeded with 1009 patients randomized in the main cohort and 410 patients in the exploratory cohort Topline results from NATiV3 projected in the second half of 2026 and, if positive, expected to be the basis for submission for regulatory …

Inventiva annonce la fin du recrutement de l’étude clinique de Phase 3 NATiV3 évaluant lanifibranor chez les patients atteints de MASH et de fibrose avancée

Inventiva annonce la fin du recrutement de l’étude clinique de Phase 3 NATiV3 évaluant lanifibranor chez les patients atteints de MASH et de fibrose avancée

Objectifs de recrutement dépassés avec 1.009 patients randomisés dans la cohorte principale et 411 dans la cohorte exploratoire Principaux résultats de NATiV3 attendus au deuxième semestre 2026 et, si positifs, ils supporteront les demandes règlementaires …

Helios Fairfax Partners to Host Investor Presentation on Wednesday, April 9, 2025, at 2:30 pm ET and Annual and Special Meeting of Shareholders on Wednesday, May 14, 2025, at 11:00 am ET

Helios Fairfax Partners to Host Investor Presentation on Wednesday, April 9, 2025, at 2:30 pm ET and Annual and Special Meeting of Shareholders on Wednesday, May 14, 2025, at 11:00 am ET

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Helios Fairfax Partners Corporation (TSX: HFPC.U) (“HFP”) today announced it will host an Investor Presentation on …

Pennant Expands Portfolio with Acquisition of Senior Living Community in Arizona

Pennant Expands Portfolio with Acquisition of Senior Living Community in Arizona

EAGLE, Idaho, April 01, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces the acquisition of the real estate and …

BioStem Technologies Announces Extension to File 2024 Annual Report with OTC

BioStem Technologies Announces Extension to File 2024 Annual Report with OTC

POMPANO BEACH, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company specializing in the development, manufacturing, and commercialization of placental-derived products for advanced wound care, announces …

Guggenheim Investments Announces April 2025 Closed-End Fund Distributions

Guggenheim Investments Announces April 2025 Closed-End Fund Distributions

NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Guggenheim Investments today announced that certain closed-end funds have declared their distributions. The table below summarizes the distribution schedule for each closed-end fund (collectively, the “Funds” …

Venus Concept Announces $11 million Debt-to-Equity Exchange Transaction

Venus Concept Announces $11 million Debt-to-Equity Exchange Transaction

TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that, on March 31, 2025, the Company exchanged $11.0 million of its subordinated …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service